NSPR - InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday March 6th | Benzinga
-Conference call and webcast to be held at 8:30 a.m. EST-
TEL AVIV, Israel and MIAMI, Feb. 28, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report fourth quarter and full-year 2023 financial results on Wednesday, March 6th, 2024, before the financial markets open.
Management will host a conference call and webcast with the investment community at 8:30 am (EST) that same day to review financial results and provide an update on corporate developments.
| Title: |
| InspireMD Fourth Quarter and Full-Year 2023 Financial Results and Corporate Update Conference Call and Webcast |
| Date: |
| Wednesday, March 6th, 2024 |
| Time: |
| 8:30 a.m. ET |
| Conference Call Details: |
| Toll-Free: 1-877-407-4018 International: 1-201-689-8471 Conference ID: 13744173 To utilize the Call me™ feature, click here. |